In summary, these results suggest that CCDC134 was involved in hormone receptor levels. Since the efficacy and prognosis of endocrine therapy for breast cancer were closely related to hormone receptor expression level, the results indicated that CCDC134 might be a biomarker of efficacy and prognosis of BC. Here, NR4A1 is linked to breast carcinoma.